MindBio Appoints Market Maker Venture Liquidity Providers
VANCOUVER, British Columbia, April 14, 2026 (GLOBE NEWSWIRE) — MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF), (the “Company” or “MindBio”), a biotechnology company commercializing AI-driven voice analytics for drug and alcohol intoxication detection, is pleased to announce subject to regulatory and final approvals, the Company has appointed market making services of Venture Liquidity […]
Original Source
Read the full article at Financialpost →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.